Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 15;2012(8):CD006987.
doi: 10.1002/14651858.CD006987.pub2.

Antivirals for idiopathic sudden sensorineural hearing loss

Affiliations

Antivirals for idiopathic sudden sensorineural hearing loss

Zaid Awad et al. Cochrane Database Syst Rev. .

Abstract

Background: Idiopathic sudden sensorineural hearing loss (ISSHL) is characterised by sudden loss of hearing of cochlear or retro-cochlear origin without an identifiable cause. Antivirals are commonly prescribed, but there is no consensus on the treatment regimen or their effectiveness.

Objectives: To determine the effectiveness and side effect profile of antivirals in the treatment of ISSHL.

Search methods: We systematically searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 5), PubMed, EMBASE, CINAHL and other databases to 12 June 2012. We also scanned the reference lists of identified studies for further trials.

Selection criteria: Randomised controlled trials comparing different antivirals versus placebo (both with or without other treatment).

Data collection and analysis: Two authors independently extracted data, met to resolve disagreements and contacted study authors for further information. We assessed study risk of bias independently. We considered meta-analysis inappropriate and ultimately not possible due to differing treatment protocols of varying dose and duration, together with differing inclusion criteria and outcome measures between studies. The results of each study are reported individually.

Main results: We included four randomised trials (257 participants). The overall risk of bias in the included studies was low. Two trials compared the addition of intravenous acyclovir to a steroid (prednisolone). One included 43 participants, the other 70 patients. Neither demonstrated any hearing improvement with ISSHL. Another (84 patients) did not show any statistically significant difference between groups with the addition of valacyclovir to prednisolone (compared to steroid plus placebo) with respect to change in pure-tone audiogram. Comparing the addition of intravenous acyclovir to hydrocortisone with hydrocortisone alone, the final trial did not show any statistically significant difference between groups (60 patients). No trial documented any serious adverse effects related to the use of antiviral treatment. One study reported slight to moderate nausea equally in the acyclovir and placebo groups (one patient in each). Another reported insomnia, nervousness and weight gain with valacyclovir (number not specified). Even though no meta-analysis was possible, evidence from the four RCTs has demonstrated no statistically significant advantage in the use of antivirals in the treatment of ISSHL.

Authors' conclusions: There is currently no evidence to support the use of antiviral drugs in the treatment of ISSHL. The four trials included in this review were, however, small and with a low risk of bias. Further randomised controlled trials with larger patient populations, using standardised inclusion criteria, antiviral regimes and outcome measures, are needed in order for adequate meta-analysis to be performed to reach definitive conclusions. A uniform definition of ISSHL should also be established, together with what constitutes adequate recovery.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
2
2
'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Update of

  • doi: 10.1002/14651858.CD006987

Similar articles

Cited by

References

References to studies included in this review

Stokroos 1998 {published data only}
    1. Stokroos RJ, Albers FW, Tenvergert EM. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double‐blind CT. Acta Oto‐laryngologica 1998;118(4):488‐95. - PubMed
Tucci 2002 {published data only}
    1. Tucci DL, Farmer JC Jr, Kitch RD, Witsell DL. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otology & Neurotology 2002;23(3):301‐8. - PubMed
Uri 2003 {published data only}
    1. Uri N, Doweck I, Cohen‐Kerem R, Greenberg E. Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngology ‐ Head and Neck Surgery 2003;128(4):544‐9. - PubMed
Westerlaken 2003 {published data only}
    1. Westerlaken BO, Stokroos RJ, Dhooge IJM, Wit HP, Albers FWJ. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double‐blind clinical trial. Annals of Otology, Rhinology and Laryngology 2003;112(11):993‐1000. - PubMed

References to studies excluded from this review

Zadeh‐Mani 2003 {published data only}
    1. Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden‐onset sensorineural hearing loss: a study of 51 patients. Otolaryngology ‐ Head and Neck Surgery 2003;128(1):92‐8. - PubMed

Additional references

Agarwal 2009
    1. Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD003422.pub4] - DOI - PMC - PubMed
Bennett 2007
    1. Bennett M, Kertesz T, Yeung P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004739.pub3] - DOI - PubMed
Conlin 2007a
    1. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Archives of Otolaryngology ‐ Head and Neck Surgery 2007;133(6):573‐81. - PubMed
Conlin 2007b
    1. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A meta‐analysis. Archives of Otolaryngology ‐ Head and Neck Surgery 2007;133(6):582‐6. - PubMed
DeKleyn 1944
    1. DeKleyn A. Sudden complete or partial loss of function of the octavus‐system in apparently normal person. Acta Oto‐laryngologica 1944;32:407‐29.
Eisenman 2000
    1. Eisenman DJ, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss. Archives of Otolaryngology ‐ Head and Neck Surgery 2000;126:1161‐4. - PubMed
Fukuda 1994
    1. Fukuda S, Furuta Y, Takasu T, Suzuki S, Inuyama Y, Nagashima K. The significance of herpes viral latency in the spiral ganglia. Acta Oto‐Laryngologica. Supplement 1994;514:108‐10. - PubMed
Goodhill 1971
    1. Goodhill V. Sudden deafness and round window rupture. Laryngoscope 1971;81(9):1462‐74. - PubMed
Goodhill 1980
    1. Goodhill W. The "idiopathic group" and the "labyrinthine window rupture group" approaches to sudden sensorineural hearing loss. In: Snow JB Jr editor(s). Controversy in Otolaryngology. Philadelphia: Saunders, 1980:12‐20.
Gussen 1976
    1. Gussen R. Sudden deafness of vascular origin: a human temporal bone study. Annals of Otology, Rhinology and Laryngology 1976;85(1 Pt 1):94‐100. - PubMed
Handbook 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Horn 2005
    1. Horn CE, Himel HN, Selesnick SH. Hyperbaric oxygen therapy for sudden sensorineural hearing loss: a prospective trial of patients failing steroid and antiviral treatment. Otology & Neurotology 2005;26(5):882‐9. - PubMed
Jeyakumar 2006
    1. Jeyakumar A, Francis D, Doerr T. Treatment of idiopathic sudden sensorineural hearing loss. Acta Oto‐laryngologica 2006;126(7):708‐13. - PubMed
Lackner 2009
    1. Lackner A, Acham A, Alborno T, Moser M, Engele H, Raggam RB, et al. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. Journal of Laryngology and Otology 2009;123(4):391‐6. - PubMed
Lazarini 2006
    1. Lazarini PR, Camargo AC. Idiopathic sudden sensorineural hearing loss: etiopathogenic aspects. Brazilian Journal of Otorhinolaryngology 2006;72(4):554‐61. - PMC - PubMed
McCabe 1979
    1. McCabe BF. Autoimmune sensorineural hearing loss. Annals of Otology, Rhinology and Laryngology 1979;88(5 Pt 1):585‐9. - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Schuknecht 1986
    1. Schuknecht HF, Donovan ED. The pathology of idiopathic sudden sensorineural hearing loss. Archives of Oto‐rhino‐laryngology 1986;243(1):1‐15. - PubMed
Stokroos 1999
    1. Stokroos RJ, Albers FW, Schirm J. Therapy of idiopathic sudden sensorineural hearing loss: antiviral treatment of experimental herpes simplex virus infection of the inner ear. Annals of Otology, Rhinology and Laryngology 1999;108(5):423‐8. - PubMed
Tucci 2000
    1. Tucci DL. Sudden sensorineural hearing loss: a viral etiology?. Archives of Otolaryngology ‐ Head and Neck Surgery 2000;126(9):1164‐5. - PubMed
Wei 2006
    1. Wei BPC, Mubiru S, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD003998.pub2] - DOI - PubMed
Wilson 1980
    1. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double‐blind clinical study. Archives of Otolaryngology 1980;106(12):772‐6. - PubMed
Wu 2006
    1. Wu CS, Lin HC, Chao PZ. Sudden sensorineural hearing loss: evidence from Taiwan. Audiology and Neuro‐otology 2006;11(3):151‐6. - PubMed

Publication types

MeSH terms